Immune gene therapy for kidney cancer: the search for a magic trigger
Open Access
- 28 February 2003
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 7 (2) , 153-154
- https://doi.org/10.1016/s1525-0016(02)00048-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Recent advances in kidney cancer and metastatic diseaseBJU International, 2001
- Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complexWorld Journal of Urology, 2000
- RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASEJournal of Urology, 1999
- Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell CancerJournal of Clinical Oncology, 1999
- Kidney cancerThe Lancet, 1998
- Dendritic cells and the control of immunityNature, 1998
- Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain.The Journal of Experimental Medicine, 1993
- New insights into T-cell antigen receptor structure and signal transductionCurrent Opinion in Immunology, 1992
- Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidneyInternational Journal of Cancer, 1986